Business / Finance

RSS

Par Pharmaceutical enters definitive agreement to acquire Anchen

Par Pharmaceutical Companies, Inc. announced today that it entered into a definitive agreement to acquire Anchen Pharmaceuticals, a privately-held specialty pharmaceutical company focused on developing and commercializing extended release and niche generic products, for $410 million in cash.

24 Aug 2011

Neovasc second quarter revenues decrease 8% to $879,405

Neovasc Inc., today announced financial results for the three and six months ended June 30, 2011.

24 Aug 2011

Square 1 Bank extends $6M credit facility to oxygen therapy innovator, Inogen

Square 1 Bank, the exclusive banking partner to entrepreneurs and the venture capital community, proudly announces the extension of a $6 million credit facility to oxygen therapy innovator, Inogen, Inc.

24 Aug 2011

Call for open challenges in nanomedicine

"Nanomedicine is certainly the most promising enabling technology to achieve breakthroughs in medical technologies. It will strongly contribute to driving the future of medicine. A first step to initiate the necessary actions will be done in October in Barcelona." says Bertrand Loubaton, Director at GE Healthcare and chairman of the European Technology Platform ETPN.

24 Aug 2011

Children's Healthcare of Atlanta acquires Toshiba's Aplio MX ultrasound system

To improve clinical performance in fetal echocardiography with advanced imaging applications, Children's Healthcare of Atlanta has acquired Toshiba America Medical Systems, Inc.'s Aplio MX ultrasound system for the Children's Sibley Heart Center fetal echo program.

24 Aug 2011

AmSurg to purchase NSC's assets for $135 million in cash

Christopher A. Holden, President and Chief Executive Officer of AmSurg Corp., today announced that AmSurg and National Surgical Care (NSC) have signed a revised definitive agreement under which AmSurg will purchase substantially all of NSC's assets for $135 million in cash.

24 Aug 2011

inVentiv Health announces launch of new European company

inVentiv Health, offering best-in-class clinical, commercial and consulting services to the healthcare industry, announced the launch of inVentiv Health Communications/Europe, a new company that brings together inVentiv's advertising, public relations, public policy, market access, medical education, marketing, branding and digital services in a unified offering serving Europe.

24 Aug 2011

Occlutech to close 15 million Euro investment

Occlutech, a leading European developer of medical implants treating structural heart disease such as PFO, ASD and LAA today announced the closing of a 15 million Euro investment into Occlutech.

24 Aug 2011

Ensign acquires Whittier Hills, Ukiah healthcare center in California

The Ensign Group, Inc., announced today that it has acquired the underlying real estate and other operating assets of Whittier Hills Healthcare Center, a 160-bed skilled nursing facility in Whittier, California and Ukiah Healthcare Center, a 57-bed skilled nursing facility in Ukiah, California.

24 Aug 2011

GNC agrees to acquire LuckyVitamin.com

GNC Holdings, Inc., a leading global specialty retailer of nutritional products, today announced it has agreed to acquire LuckyVitamin.com, a leading online value-added retailer of a wide range of nationally branded nutritional supplements with a diverse selection of wellness-oriented products.

24 Aug 2011

Thermo Fisher acquires Phadia

Thermo Fisher Scientific Inc., the world leader in serving science, today reported that it has completed its previously announced acquisition of Phadia, a global leader in blood tests for the clinical diagnosis and monitoring of allergies and autoimmune diseases.

From Thermo Fisher Scientific Inc. 24 Aug 2011

MedPro Safety Products second quarter net loss decreases to $2.9 million

MedPro Safety Products, Inc., a leading developer of transformational technologies that enable safer medication delivery and blood collection, today reported on several key financial highlights for the second quarter ended June 30, 2011, as well as significant corporate developments.

23 Aug 2011

BioLineRx second quarter net loss decreases to NIS 16.4 million

BioLineRx Ltd., a biopharmaceutical development company, today reported its results for the second quarter ending June 30, 2011.

23 Aug 2011

Medtronic first quarter global revenue increases 7% to $4.049 billion

Medtronic, Inc. today announced financial results for its first quarter of fiscal year 2012, which ended July 29, 2011.

From Medtronic 23 Aug 2011

Nepstar board authorizes share repurchase program

China Nepstar Chain Drugstore Ltd., the largest drugstore chain in China based on the number of directly operated stores, today announced that its board of directors has authorized a share repurchase program.

23 Aug 2011

KalVista raises £8 million in series A round of funding

KalVista Pharmaceuticals, a new ophthalmology company with a focus on diabetic macular edema (DME), has raised £8 million in a series A round from leading life sciences investors Novo A/S and SV Life Sciences.

23 Aug 2011

Spinifex secures AU$6.25 million in expanded Series B funding

Spinifex Pharmaceuticals, an Australian pain drug development company, today announced it has secured a further AU$6.25 million of venture capital investment from GBS Venture Partners Limited, Brandon Capital Partners Pty Limited, Uniseed Management Pty Limited and UniQuest Pty Limited to fund the development of its pain management drug, EMA401.

23 Aug 2011

NextDocs receives $10.3 million in Series A financing

NextDocs Corporation, the global leader in Microsoft SharePoint based software solutions for life sciences industries, today announced that the Company has received $10.3 million in a Series A financing from OpenView Venture Partners.

23 Aug 2011

Crimson announces publication of Japan Medical Device Digest

Crimson Life Sciences, a division of TransPerfect and the world's only ISO 13485 and ISO 14971-certified translation provider, today announced the publication of their Japan Medical Device Digest, a free monthly report that provides English translations of Japanese-language news items.

23 Aug 2011

CVS Caremark announces results of Consent Solicitation from registered holders

CVS Caremark Corporation announced today the results of its previously announced solicitation of consents from the registered holders as of 5:00 p.m., New York City time on August 8, 2011 of its 6.125% Senior Notes due August 15, 2016 to terminate the replacement capital covenant, which was entered into on May 25, 2007, for the benefit of the holders of the Notes in connection with the issuance of its 6.302% Enhanced Capital Advantaged Preferred Securities due 2062.

23 Aug 2011